Tradingfxdaily.com
  • Home
  • Forex
  • Crypto News
    • NFT News
  • World News
  • Business
  • Stock Market
  • Economic Calendar
No Result
View All Result
  • Home
  • Forex
  • Crypto News
    • NFT News
  • World News
  • Business
  • Stock Market
  • Economic Calendar
No Result
View All Result
Tradingfxdaily.com
No Result
View All Result
Home Stock Market

Invitae Goes Full Meme Stock. What’s Next?

tradingfxdaily by tradingfxdaily
August 15, 2022
in Stock Market
0
Invitae Goes Full Meme Stock. What’s Next?
189
SHARES
1.5k
VIEWS
Share on FacebookShare on Twitter

Related articles

Elon Musk Wants to Build ‘Ecological Paradise’ With ‘Retro-Futuristic Boats’

Elon Musk Warns Italy Is Dying

January 29, 2023
FTX Collapse: Bankman-Fried Wants to Avoid Arrest on US Soil

FTX: DOJ Seeks to Ban Bankman-Fried From Using Signal, Slack to Contact Employees

January 29, 2023

A little momentum and a big short squeeze can go a long way. Genetic testing platform Invitae  (NVTA)  ripped 277% higher on August 10. It was truly epic.

Roughly 217 million shares traded hands. For comparison, the average daily trading volume was just 13.7 million shares over the previous three months. Furthermore, the business entered August with only about 235 million shares outstanding total.

It was also truly bizarre. Invitae announced a strategic pivot and provided financial guidance on July 18. That included unflattering growth projections, replacing the CEO, laying off one-third of its workforce, and promising to keep cash burn to “only” $825 million in 2022 and 2023. Nothing changed when it reported second-quarter 2022 operating results on August 9.

Investors might argue the genetic testing platform was undervalued at a market valuation of $500 million, which is where the valuation settled in the weeks after the pivot was announced. Then again, there’s not much to look forward to until 2024.

Momentum Is Not a Durable Advantage

Many companies pursued a growth-at-all-costs business model, which promises potential profits many years in the future, over the last decade. That was easy to do when the Federal Reserve kept interest rates low to spur growth and keep the economy from slipping into a deflationary environment after the Great Recession. The easy-money era is coming to an abrupt end in the aftermath of the coronavirus pandemic, for which the economic recovery is characterized by some of the opposite challenges.

Pledges (and actions) to jack up interest rates virtually overnight have exposed the unsustainable nature of growth-at-all-costs business models. Now, many companies large and small are prioritizing traditional metrics of business success, such as cash flows and profitability. Some are better positioned than others.

Invitae was among the worst positioned. It spent money a little carelessly, prioritized revenue growth over every other metric, and wasn’t delivering any financial benefits from achieving larger scale. From 2018 to 2021, the business grew revenue 212%, but only grew gross profit 63%. That’s a problem when operating expenses grow 302%. The result was unsurprising: Operating cash outflows swelled 507% in that span.

That trend was never sustainable. It necessitated a pivot and a new focus on operating efficiency. The strategic reset was finally announced in July, but investors should acknowledge the improvements will still make Invitae a relatively lousy business. 

Scroll to Continue

Let’s consider a little perspective:

  • Invitae plans to report a cash burn of roughly $600 million in 2022. That will be more than Exact Sciences  (EXAS) , which generates more revenue every quarter than Invitae generates in a year.
  • Invitae plans to reduce cash burn to roughly $225 million in 2023. That will be roughly equivalent to PacBio  (PACB) , which generates 70% less revenue than Invitae.
  • Cash burn guidance suggests Invitae will enter 2024 with roughly $210 million in cash – likely only enough for another 12 months of operations. Companies typically make that the minimum level of cash on the balance sheet, suggesting another capital raise will be needed in late 2023 or early 2024.
  • Invitae plans to wind down certain aspects of its business. It doesn’t expect total revenue to grow in 2023 compared to 2022. When growth resumes in 2024, management expects an annual rate of 15% to 25% — much lower than the historical promises of 40% annual growth.

Promising to be less bad 24 months from now is hardly cause for celebration.

Is This the Real Reason for the Pivot?

My read on the situation is that management’s strategic pivot is an attempt to make Invitae more attractive for an acquisition. However, most would-be suitors are also furiously focusing on improving cash flow and achieving profitable growth. That alone makes it difficult to see an acquisition taking place any time soon, even if the described operating improvements are achieved.

Does Exact Sciences or Roche  (RHHBY)  or Guardant Health  (GH)  really want to spend $2 billion or more on an acquisition for the privilege of burning hundreds of millions of dollars per year in a commoditized industry? It’s possible, but there are more attractive acquisition targets in the fragmented landscape of genetic testing. Besides, it may be more valuable to let a competitor crash and burn, opening more elbow room in the commercial landscape.

To be fair, there are opportunities for positive surprises. Invitae could divest parts of the platform.

One of the best moves would be to offload its recently-acquired liquid biopsy portfolio. The tools are delayed, well behind the competitive landscape, and the company doesn’t have the correct commercial infrastructure built to achieve success. Such a sale could provide hundreds of millions of dollars in cash, allow the business to focus on core hereditary testing, and make it more appealing for an acquisition itself — both from a financial and anti-trust standpoint. Management intends to keep the liquid biopsy tools for now.

Whether bullish or bearish, investors should remain grounded. It’s premature to take a victory lap on the mere announcement of plans to improve from very poor benchmarks. Even if successful, Invitae is likely to enter 2024 as a deeply unprofitable business, which will present challenges. The current momentum and volatility are certainly fun, but focus on meaningful metrics and durable outcomes. It will take years to play out.



Source link

Share76Tweet47

Related Posts

Elon Musk Wants to Build ‘Ecological Paradise’ With ‘Retro-Futuristic Boats’

Elon Musk Warns Italy Is Dying

by tradingfxdaily
January 29, 2023
0

Elon Musk is sounding the alarm again. The billionaire has made it a habit now: alerting the world to urgent and...

FTX Collapse: Bankman-Fried Wants to Avoid Arrest on US Soil

FTX: DOJ Seeks to Ban Bankman-Fried From Using Signal, Slack to Contact Employees

by tradingfxdaily
January 29, 2023
0

The founder and former CEO of bankrupt cryptocurrency exchange FTX, Sam Bankman-Fried, was accused of reaching out to the general counsel...

McDonald’s Fries Up (Yes, Fries) Some Unique New Burgers

McDonald’s Teases Major Disney World Surprise

by tradingfxdaily
January 29, 2023
0

Happy Meals at McDonald’s are a kids' dream come true, getting one of those little cardboard lunch boxes includes everything a...

Is Elon Musk a Fan of Marijuana?

Elon Musk Makes Suggestion That May Deepen Divisions in Germany

by tradingfxdaily
January 29, 2023
0

Germany has been immersed since last year in a debate raising passions and dividing its government coalition.The object of the...

Caesars, Las Vegas Strip Welcome a Huge Celebrity

Donald Trump’s Las Vegas Strip Hotel Gets a Dubious Honor

by tradingfxdaily
January 29, 2023
0

Architect Frank Lloyd Wright designed some of the most famous and visually appealing buildings in the United States and the world, including...

Load More
  • Trending
  • Comments
  • Latest
Short SPX: Top Trade Opportunities

Short SPX: Top Trade Opportunities

April 5, 2022
The Top 5 Metaverses to Look Out for in 2022

The Top 5 Metaverses to Look Out for in 2022

March 26, 2022
What is Leverage in Forex? Forex Leverage Explained

What is Leverage in Forex? Forex Leverage Explained

April 19, 2022

Larry Fink says globalization is over — Here’s what it means for the markets

March 26, 2022
Tesla Stock Split: What to Know as EV Maker Prepares to Split Its Stock in 2022

Tesla Stock Split: What to Know as EV Maker Prepares to Split Its Stock in 2022

March 28, 2022
Elon Musk Wants to Build ‘Ecological Paradise’ With ‘Retro-Futuristic Boats’

Elon Musk Warns Italy Is Dying

0

In a Less-Globalized World, Be Careful Where You Park Your Plane

0
Cardano pares most of its Q1 losses as ADA rebounds 60% in a month — What’s next? By Cointelegraph

Cardano pares most of its Q1 losses as ADA rebounds 60% in a month — What’s next? By Cointelegraph

0

Larry Fink says globalization is over — Here’s what it means for the markets

0
Natural-Gas Industry Gets Boost as Biden Shifts Stance

Natural-Gas Industry Gets Boost as Biden Shifts Stance

0
Elon Musk Wants to Build ‘Ecological Paradise’ With ‘Retro-Futuristic Boats’

Elon Musk Warns Italy Is Dying

January 29, 2023
Litecoin Displays Consolidation, Expect A Reversal Soon?

Litecoin Displays Consolidation, Expect A Reversal Soon?

January 29, 2023
S&P 500 ends higher with financials as Treasury yields jump By Reuters

Russia rules out talks with Japan on fishing near disputed islands By Reuters

January 29, 2023
European equity close: Another week of gains but the momentum slows

European equity close: Another week of gains but the momentum slows

January 29, 2023
Boris Johnson: Britain will be sucked back into EU’s orbit if Labour take over

Boris Johnson: Britain will be sucked back into EU’s orbit if Labour take over

January 29, 2023
Tradingfxdaily.com

Tradingfxdaily.com is your Forex, Stock News, World News, Crypto Currency News, Business News & NFT News Website. We provide you with the latest breaking news and videos straight from the Trading industry.

  • Home
  • About us
  • Contact Us
  • Privacy Policy

© 2022 - All Right Reserved. tradingfxdaily.com

No Result
View All Result
  • Home
  • Forex
  • Crypto News
    • NFT News
  • World News
  • Business
  • Stock Market
  • Economic Calendar

© 2022 - All Right Reserved. tradingfxdaily.com

EURUSD=X 
$1.09  -0.16%  
EURCAD=X 
$1.45  -0.28%  
EURJPY=X 
$141.09  -0.45%  
GBPUSD=X 
$1.24  -0.10%  
EURNZD=X 
$1.67  -0.27%  
AUDUSD=X 
$0.7106  -0.15%  
CADUSD=X 
$0.7514  0.10%